Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinosarcoma × pazopanib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 58 Sarcoma 34 Neoplasms 20 Neoplasm Metastasis 19 Breast Neoplasms 17 Ovarian Neoplasms 15 Carcinoma, Non-Small-Cell Lung 13 Leiomyosarcoma 6 Kidney Neoplasms 6 Hemangiosarcoma 6 Thyroid Neoplasms 5 Recurrence 5 Melanoma 5 Lung Neoplasms 5 Liposarcoma 5 Glioblastoma 5 Fallopian Tube Neoplasms 5 Urinary Bladder Neoplasms 4 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Osteosarcoma 4 Neurofibrosarcoma 4 Clear-cell metastatic renal cell carcinoma 4 Sarcoma, Synovial 3 Sarcoma, Alveolar Soft Part 3 Neuroendocrine Tumors 3 Histiocytoma, Malignant Fibrous 3 Gliosarcoma 3 Gastrointestinal Stromal Tumors 3 Fibrosarcoma 3

Interventions

Specimen Handling 8 Paclitaxel 6 Magnetic Resonance Spectroscopy 6 Nivolumab 5 Carboplatin 5 Biopsy 5 pembrolizumab 3 X-Rays 3 olaparib 2 ceralasertib 2 Taxes 2 trastuzumab deruxtecan 1 sargramostim 1 rucaparib 1 ribociclib 1 pelcitoclax 1 pazopanib 1 pamiparib 1 durvalumab 1 cobimetinib 1 cediranib 1 cabozantinib 1 belinostat 1 atezolizumab 1 Tissue Banks 1 TIC10 compound 1 Radiation 1 Phantoms, Imaging 1 Minimally Invasive Surgical Procedures 1 LY-2157299 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02203760 2024-11-15

PazoDoble

North Eastern German Society of Gynaecological Oncology

Phase 2 Active not recruiting

Carcinosarcoma, Leiomyosarcoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡